AstraZeneca's new TV ad for Farxiga focuses on chronic kidney disease indication

As­traZeneca adds chron­ic kid­ney dis­ease TV ad to Farx­i­ga port­fo­lio

As­traZeneca is adding a third ar­row to its Farx­i­ga TV ad quiver. De­but­ing to­day, the new com­mer­cial takes aim at chron­ic kid­ney dis­ease, fol­low­ing AZ’s long-time TV ad­ver­tis­ing of the SGLT2 in­hibitor for Type 2 di­a­betes and more re­cent­ly heart fail­ure.

Chron­ic kid­ney dis­ease (CKD) is on the rise, af­fect­ing an es­ti­mat­ed one in sev­en or about 37 mil­lion US adults. How­ev­er, nine out of 10 peo­ple with CKD have not been di­ag­nosed, ac­cord­ing to da­ta from the CDC.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.